Literature DB >> 12165431

The fluorolysis assay, a highly sensitive method for measuring the cytolytic activity of T cells at very low numbers.

Norbert Kienzle1, Stuart Olver, Kathy Buttigieg, Anne Kelso.   

Abstract

We have developed a highly sensitive cytolysis test, the fluorolysis assay, as a simple nonradioactive and inexpensive alternative to the standard 51Cr-release assay. P815 cells were stably transfected with a plasmid expressing the enhanced green fluorescent protein (EGFP) gene. These target cells were coated with or without cognate peptide or anti-CD3 Ab and then incubated with CD8(+) T cells to allow antigen-specific or nonspecific lysis. The degree of target cell lysis was measured using flow cytometry to count the percentage of viable propidium iodide(-) EGFP(+) cells, whose numbers were standardized to a reference number of fluorochrome-linked beads. By using small numbers of target cells (200-800 per reaction) and extended incubation times (up to 2 days), the antigen-specific cytolytic activity of one to two activated CD8(+) T cells of a CTL line could be detected. The redirected fluorolysis assay also measured the activity of very few (> or =6) primary CD8(+) T cells following polyclonal activation. Importantly, antigen-specific lysis by small numbers (> or =25) of primary CD8(+) T cells could be directly measured ex vivo. This exquisite sensitivity of the fluorolysis assay, which was at least 8-33-folds higher than an optimized 51Cr-release assay, allows in vitro and ex vivo studies of immune responses that would otherwise not be possible due to low CTL numbers or frequencies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165431     DOI: 10.1016/s0022-1759(02)00150-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  13 in total

1.  In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping.

Authors:  Susanne Reuther; Helga Schmetzer; Friedhelm R Schuster; Pina Krell; Christine Grabrucker; Anja Liepert; Tanja Kroell; Hans-Jochem Kolb; Arndt Borkhardt; Raymund Buhmann
Journal:  Clin Exp Med       Date:  2012-03-23       Impact factor: 3.984

2.  NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.

Authors:  Edward S Morris; Kelli P A MacDonald; Vanessa Rowe; Tatjana Banovic; Rachel D Kuns; Alistair L J Don; Helen M Bofinger; Angela C Burman; Stuart D Olver; Norbert Kienzle; Steven A Porcelli; Daniel G Pellicci; Dale I Godfrey; Mark J Smyth; Geoffrey R Hill
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

Review 3.  New flow cytometric assays for monitoring cell-mediated cytotoxicity.

Authors:  Liubov Zaritskaya; Michael R Shurin; Thomas J Sayers; Anatoli M Malyguine
Journal:  Expert Rev Vaccines       Date:  2010-06       Impact factor: 5.217

4.  Interferon Gamma Secretion of Adaptive and Innate Immune Cells as a Parameter to Describe Leukaemia-Derived Dendritic-Cell-Mediated Immune Responses in Acute Myeloid Leukaemia in vitro.

Authors:  Lara Kristina Klauer; Olga Schutti; Selda Ugur; Fatemeh Doraneh-Gard; Daniel Christoph Amberger; Nicole Rogers; Doris Krämer; Andreas Rank; Christoph Schmid; Britta Eiz-Vesper; Helga Maria Schmetzer
Journal:  Transfus Med Hemother       Date:  2021-07-07       Impact factor: 3.747

5.  Interleukin-4-induced loss of CD8 expression and cytolytic function in effector CD8 T cells persists long term in vivo.

Authors:  Stuart Olver; Simon H Apte; Adriana Baz; Anne Kelso; Norbert Kienzle
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

6.  Pancreatic lipase-related protein 2 (PLRP2) induction by IL-4 in cytotoxic T lymphocytes (CTLs) and reevaluation of the negative effects of its gene ablation on cytotoxicity.

Authors:  Bryce N Alves; Jeff Leong; David L Tamang; Viki Elliott; Jillian Edelnant; Doug Redelman; Cherie A Singer; Andrew R Kuhn; Rita Miller; Mark E Lowe; Dorothy Hudig
Journal:  J Leukoc Biol       Date:  2009-05-18       Impact factor: 4.962

7.  Hydrolysis of tumor cell lipids after CTL-mediated death.

Authors:  Bryce Alves; Jeff Leong; David L Tamang; Viki Elliott; Mark Lowe; Dorothy Hudig
Journal:  Int Immunol       Date:  2009-03-26       Impact factor: 4.823

8.  Lipid-dependent cytotoxicity by the lipase PLRP2 and by PLRP2-positive cytotoxic T lymphocytes (CTLs).

Authors:  Bryce N Alves; Kristen Marshall; David L Tamang; Jeffrey Leong; Doug Redelman; Viki Elliott; Mark E Lowe; Dorothy Hudig
Journal:  Cell Biochem Funct       Date:  2009-07       Impact factor: 3.685

9.  The role of ACAID and CD4+CD25+FOXP3+ regulatory T cells on CTL function against MHC alloantigens.

Authors:  Daniel R Saban; Janet Cornelius; Sharmila Masli; Johannes Schwartzkopff; Maire Doyle; Sunil K Chauhan; Ammon B Peck; Maria B Grant
Journal:  Mol Vis       Date:  2008-12-19       Impact factor: 2.367

10.  A novel method for producing target cells and assessing cytotoxic T lymphocyte activity in outbred hosts.

Authors:  Francesca Bonci; Elisa Zabogli; Francesca Conti; Antonio Merico; Giulia Freer; Mauro Bendinelli; Mauro Pistello
Journal:  BMC Biotechnol       Date:  2009-03-11       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.